WHITNEY GARDINER

Issues relating to the continued suspension of the medical device tax.

H.R.6/H.R. 34- 21st Century Cures Act- provisions related to medical innovation, technology and medical device regulatory reforms. S.2998/H.R.5009- Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Issues related to Pandemic Preparedness. S.1767- The Combination Product Regulatory Fairness Act- Provisions related to combination products.

Issues related to competitive bidding for DME products. H.R. 5210 and S. 2736- Patient Access to Durable Medical Equipment Act- provisions related to patient access. H.R. 1427/S.804- Medicare CGM Access Act of 2015- Provisions related to continuous glucose monitoring.

H.R.6- 21st Century Cures Act- provisions related to medical innovation, technology and medical device regulatory reforms. S.2998/H.R.5009- Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Issues related to Pandemic Preparedness. S.1767- The Combination Product Regulatory Fairness Act- Provisions related to combination products. Education about FDA regulation of hysteroscopic morcellators.

Issues relating to the continued suspension of the medical device tax.

Issues related to competitive bidding for DME products. H.R. 5210 and S. 2736- Patient Access to Durable Medical Equipment Act- provisions related to patient access. H.R. 1427/S.804- Medicare CGM Access Act of 2015- Provisions related to continuous glucose monitoring.

H.R.6- 21st Century Cures Act- provisions related to medical innovation, technology and medical device regulatory reforms. Issues related to Brain Aneurysm Awareness and Funding. S.Res 438- Designating September 2016 as "National Brain Aneurysm Awareness Month." S.2998/H.R.5009- Ensuring Patient Access to Critical Breakthrough Products Act of 2016. Issues related to Pandemic Preparedness.

S. 2658- The Federal Aviation Administration Reauthorization Act of 2016- Provisions related to air shipment of lithium batteries.

Issues relating to the continued suspension of the medical device tax.

Issues related to competitive bidding for DME products

Issues related to trade secrets; Issues related to copyright DMCA exemption

S. 144 Medical Device Access and Innovation Protection Act; H.R. 160 Protect Medical Innovation; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment

Issues related to free trade agreements in European Union and Asia Issues related to the statutory extension of Trade Promotion Authority.

Issues related to free trade agreements in European Union and Asia. Issues related to the statutory extension of Trade Promotion Authority.

Issues related to trade secrets; Issues related to copyright DMCA exemption.

Issues related to the 21st Century Cures initiative. Issues related to competitive bidding for DME products.

Issues related to free trade agreements in European Union and Asia.

Issues related to the 21st Century Cures initiative, a priority of the House Energy and Commerce Committee.

S. 144 Medical Device Access and Innovation Protection Act; H.R. 160 Protect Medical Innovation; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally.

Issues related to free trade agreements in European Union and Asia.

H.R. 2052/S. 1023: Global Investments in American Jobs Act of 2013 (all provisions)

S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax); S.2360/ H.R.4679 The Stop Corporate Inversions Act of 2014 (Provisions related to management and control); H.R.4985 - Stop Corporate Expatriation and Invest in America's Infrastructure Act of 2014 (Provisions related to management and control);S. 2786 Corporate Inverters Earnings Stripping Reform Act;

Issues related to free trade agreements in European Union and Asia.

H.R. 2052/S. 1023: Global Investments in American Jobs Act of 2013 (all provisions)

Issues relating to implementation of provisions of the Food and Drugs Administration Safety and Innovation Act related to device review; Issues related to sequestration of the FDA medical device user fees; Issues related to reimbursements for Transcutaneous Electronic Stimulation (TENS) therapy for chronic low back pain; Issue regarding the Hospital Outpatient Prospective Payment System and the proposed changes to the reimbursement of certain vascular procedures. Issues related to SGR legislation and the provision to create a CMS pilot program to encourage more home-based remote monitoring. Issue related to medicare coverage of early lung cancer screening. Issues related to the 21st Century Cures initiative, a priority of the House Energy and Commerce Committee.

Issues relating to implementation of provisions of the Food and Drugs Administration Safety and Innovation Act related to device review; Issues related to sequestration of the FDA medical device user fees; Issues related to reimbursements for Transcutaneous Electronic Stimulation (TENS) therapy for chronic low back pain; Issue regarding the Hospital Outpatient Prospective Payment System and the proposed changes to the reimbursement of certain vascular procedures.Issues related to SGR legislation and the provision to create a CMS pilot program to encourage more home-based remote monitoring. Issues related to medicare coverage of early lung cancer screening.

S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).S.2360/ H.R.4679 The Stop Corporate Inversions Act of 2014 (Provisions related to management and control); H.R.4985 - Stop Corporate Expatriation and Invest in America's Infrastructure Act of 2014 (Provisions related to management and control)

S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).

Issues relating to implenentation of provisions of the Food and Drugs Advminstration Safety and Innovation Act related to device review; Issues related to sequestration of the FDA medical device user fees; Issues related to reimbursements for Transcutaneous Electronic Stimulation (TENS) therapy for chronic low back pain; Issue regarding the Hospital Outpatient Prospective Payment System and the proposed changes to the reimbursement of certain vascular procedures.Issues related to SGR legislation and the provision to create a CMS pilot program to encourage more home-based remote monitoring. Issues related to medicare coverage of early lung cancer screening.

Issues relating to sequestration of the medical device user fees; Issues related to reimbursements for Transcutaneous Electronic Stimulation (TENS) therapy for chronic low back pain; Issue regarding the Hospital Outpatient Prospective Payment System and the proposed changes to the reimbursement of certain vascular procedures. Issues related to SGR legislation and the provision to create a CMS pilot program to encourage more home-based remote monitoring.

S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).

Issues relating to sequestration of the medical device user fees; Issues related to reimbursements for Transcutaneous Electronic Stimulation (TENS) therapy for chronic low back pain; Issue regarding the Hospital Outpatient Prospective Payment System and the proposed changes to the reimbursement of certain vascular procedures. Issues related to SGR legislation and the provision to create a CMS pilot program to encourage more home-based remote monitoring.

H.R. 2052/S. 1023: Global Investments in American Jobs Act of 2013 (all provisions)

S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).

H.R. 2052/S. 1023: Global Investments in American Jobs Act of 2013 (all provisions)

Issues relating to sequestration of the medical device user fees; Issues related to reimbursements for Transcutaneous Electronic Stimulation (TENS) therapy for chronic low back pain; Issue regarding the Hospital Outpatient Prospective Payment System and the proposed changes to the reimbursement of certain vascular procedures.

S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).

Issues relating to sequestration of the medical device user fees.; Issues related to reimbursements for Transcutaneous Electronic Stimulation (TENS) therapy for chronic low back pain; Issues regarding shortages of nuclear isotopes used in production of nuclear medicine.

S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).

S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform -generally.

Issues relating to sequestration of the medical device user fees.; Issues related to reimbursements for Transcutaneous Electronic Stimulation (TENS) therapy for chronic low back pain; Issues regarding shortages of nuclear isotopes used in production of nuclear medicine.

Free Trade Agreement; HR 3078: United State Columbia Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement); HR 3079: United States Panama Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement)HR 3080: United States - Korea Free Trade Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement)

Issues involving controlled substance and pain and addiction drugs generally; H.R. 2119: Ryan Creedon Act of 2011To amend the Controlled Substances Act to require practitioners to obtain particular training or special certification, approved by the Attorney General, on addiction to and abuse of controlled substances and appropriate and safe use of controlled substances in schedule II, III, IV, or V, and for other purposes; Issues related to acetaminophen.

Free Trade Agreement; HR 3078: United State Columbia Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement); HR 3079: United States Panama Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement)HR 3080: United States - Korea Free Trade Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement)

General issues related to FDA device approval process; issues related to Patient Protection and Affordable Care Act Implementation (Accountable Care Organization, Medical Device Tax); S.17/S.262/H.R.436/H.R.488/H.R.734: Medical Device Access and Innovation Protection Act (all provisions); HEU/LEU related issues for Nuclear Medicine. S.99: American Medical Isotopes Production Act (all provisions).H.R. 3209: Premarket Predictability Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3203: Novel Device Regulatory Relief Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3230: Keeping America Competitive Through Harmonization Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3205: FDA Renewing Efficiency from Outside Review Management Act. (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3211: Humanitarian Device Reform Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3208: Patients Come First Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3206: Cultivating Scientific Experts to Foster Innovation Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3214: Food and Drug Administration Mission Reform Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3204: Guidance Accountability and Transparency Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1700: The Medical Device Regulatory Improvement Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1865: The Patient Access to Medical Innovation Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1943: Novel Device Regulatory Relief Act of 2011(All provisions related to the FDA and the regulation of medical devices generally); S. 1972: A bill to amend the Food and Drug Administrations mission (All provisions related to the FDA and the regulation of medical devices generally); S. 1995: A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes (All provisions related to the FDA and the regulation of medical devices generally)

S.23/H.R.1249: America Invents Act (all provisions).

International tax on foreign direct investment generally; Corporate Tax Reform generally; S.1346: Stop Tax Haven Abuse Act (all provisions); H.R. 62: International Tax Competitiveness Act of 2011 (all provisions).

General issues related to FDA device approval process; issues related to Patient Protection and Affordable Care Act Implementation (Accountable Care Organization, Medical Device Tax); S.17/S.262/H.R.436/H.R.488/H.R.734: Medical Device Access and Innovation Protection Act (all provisions); HEU/LEU related issues for Nuclear Medicine. S.99: American Medical Isotopes Production Act (all provisions). H.R. 3209: Premarket Predictability Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3203: Novel Device Regulatory Relief Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3230: Keeping America Competitive Through Harmonization Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3205: FDA Renewing Efficiency from Outside Review Management Act. (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3211: Humanitarian Device Reform Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3208: Patients Come First Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3206: Cultivating Scientific Experts to Foster Innovation Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3214: Food and Drug Administration Mission Reform Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3204: Guidance Accountability and Transparency Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1700: The Medical Device Regulatory Improvement Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1865: The Patient Access to Medical Innovation Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1943: Novel Device Regulatory Relief Act of 2011(All provisions related to the FDA and the regulation of medical devices generally); S. 1972: A bill to amend the Food and Drug Administrations mission (All provisions related to the FDA and the regulation of medical devices generally); S. 1995: A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes (All provisions related to the FDA and the regulation of medical devices generally); S.3187: Food and Drug Administration Safety and Innovation Act as well as Amendment 2151 on reclassification of hydrocodone sponsored by Senator Manchin; Coverage issues for Transcutaneous Electronic Stimulation for chronic lower back pain. Issue relating to MDUFA fees and sequestration.

Free Trade Agreement; HR 3078: United State Columbia Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement); HR 3079: United States Panama Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement) HR 3080: United States - Korea Free Trade Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement)

General issues related to FDA device approval process; issues related to Patient Protection and Affordable Care Act Implementation (Accountable Care Organization, Medical Device Tax); S.17/S.262/H.R.436/H.R.488/H.R.734: Medical Device Access and Innovation Protection Act (all provisions); HEU/LEU related issues for Nuclear Medicine. S.99: American Medical Isotopes Production Act (all provisions). H.R. 3209: Premarket Predictability Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3203: Novel Device Regulatory Relief Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3230: Keeping America Competitive Through Harmonization Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3205: FDA Renewing Efficiency from Outside Review Management Act. (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3211: Humanitarian Device Reform Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3208: Patients Come First Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3206: Cultivating Scientific Experts to Foster Innovation Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3214: Food and Drug Administration Mission Reform Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3204: Guidance Accountability and Transparency Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1700: The Medical Device Regulatory Improvement Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1865: The Patient Access to Medical Innovation Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1943: Novel Device Regulatory Relief Act of 2011(All provisions related to the FDA and the regulation of medical devices generally); S. 1972: A bill to amend the Food and Drug Administrations mission (All provisions related to the FDA and the regulation of medical devices generally); S. 1995: A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes (All provisions related to the FDA and the regulation of medical devices generally); S.3187: Food and Drug Administration Safety and Innovation Act as well as Amendment 2151 on reclassification of hydrocodone sponsored by Senator Manchin; Coverage issues for Transcutaneous Electronic Stimulation for chronic lower back pain.

International tax on foreign direct investment generally; Corporate Tax Reform generally; S.1346: Stop Tax Haven Abuse Act (all provisions); H.R. 62: International Tax Competitiveness Act of 2011 (all provisions).

Free Trade Agreement; HR 3078: United State Columbia Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement); HR 3079: United States Panama Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement) HR 3080: United States - Korea Free Trade Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement)

International tax on foreign direct investment generally; Corporate Tax Reform generally; S.1346: Stop Tax Haven Abuse Act (all provisions); H.R. 62: International Tax Competitiveness Act of 2011 (all provisions).

Free Trade Agreement; HR 3078: United State Columbia Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement); HR 3079: United States Panama Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement) HR 3080: United States - Korea Free Trade Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement)

Issues involving controlled substance and pain and addiction drugs generally; H.R. 2119: Ryan Creedon Act of 2011; Issues related to acetaminophen

General issues related to FDA device approval process; issues related to Patient Protection and Affordable Care Act Implementation (Accountable Care Organization, Medical Device Tax); S.17/S.262/H.R.436/H.R.488/H.R.734: Medical Device Access and Innovation Protection Act (all provisions); HEU/LEU related issues for Nuclear Medicine. S.99: American Medical Isotopes Production Act (all provisions). H.R. 3209: Premarket Predictability Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3203: Novel Device Regulatory Relief Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3230: Keeping America Competitive Through Harmonization Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3205: FDA Renewing Efficiency from Outside Review Management Act. (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3211: Humanitarian Device Reform Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3208: Patients Come First Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3206: Cultivating Scientific Experts to Foster Innovation Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3214: Food and Drug Administration Mission Reform Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3204: Guidance Accountability and Transparency Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1700: The Medical Device Regulatory Improvement Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1865: The Patient Access to Medical Innovation Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1943: Novel Device Regulatory Relief Act of 2011(All provisions related to the FDA and the regulation of medical devices generally); S. 1972: A bill to amend the Food and Drug Administrations mission (All provisions related to the FDA and the regulation of medical devices generally); S. 1995: A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes (All provisions related to the FDA and the regulation of medical devices generally)

Issues involving controlled substance and pain and addiction drugs generally. Issues related to acetaminophen.

General issues related to FDA device approval process; issues related to Patient Protection and Affordable Care Act Implementation (Accountable Care Organization, Medical Device Tax); S.17/S.262/H.R.436/H.R.488/H.R.734: Medical Device Access and Innovation Protection Act (all provisions); HEU/LEU related issues for Nuclear Medicine. S.99: American Medical Isotopes Production Act (all provisions). H.R. 3209: Premarket Predictability Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3203: Novel Device Regulatory Relief Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3230: Keeping America Competitive Through Harmonization Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3205: FDA Renewing Efficiency from Outside Review Management Act. (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3211: Humanitarian Device Reform Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3208: Patients Come First Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3206: Cultivating Scientific Experts to Foster Innovation Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3214: Food and Drug Administration Mission Reform Act (All provisions related to the FDA and the regulation of medical devices generally); H.R. 3204: Guidance Accountability and Transparency Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1700: The Medical Device Regulatory Improvement Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1865: The Patient Access to Medical Innovation Act (All provisions related to the FDA and the regulation of medical devices generally); S. 1943: Novel Device Regulatory Relief Act of 2011(All provisions related to the FDA and the regulation of medical devices generally); S. 1972: A bill to amend the Food and Drug Administrations mission (All provisions related to the FDA and the regulation of medical devices generally); S. 1995: A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes (All provisions related to the FDA and the regulation of medical devices generally)

Issues involving controlled substance and pain and addiction drugs generally. Issues related to acetaminophen.

S.23/H.R.1249: America Invents Act (all provisions).

Free Trade Agreement; HR 3078: United State Columbia Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement); HR 3079 United States Panama Trade Promotion Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement) HR 3080 United States - Korea Free Trade Agreement (All provisions relevant to medical device companies, in particular the device-specific provisions listed in the US-Korea Free Trade Agreement)

General issues related to FDA device approval process; Issues related to Patient Protection and Affordable Care Act Implementation (Accountable Care Organization Medical Device Tax); Medical Device Tax Repeal (S.17, S.262, H.R. 436, H.R. 488, H.R. 734); HEU/LEU related issues for Nuclear Medicine; S. 99 - American Medical Isotopes Production Act (all provisions).

S.23/H.R.1249 - America Invents Acts (all provisions).

International tax on foreign direct investment generally.

International tax on foreign direct investment generally; Corporate Tax Reform generally; S.1346: Stop Tax Haven Abuse Act (all provisions); H.R. 62: International Tax Competitiveness Act of 2011 (all provisions).

General issues related to FDA device approval process; issues related to Patient Protection and Affordable Care Act Implementation (Accountable Care Organization, Medical Device Tax); S.17/S.262/H.R. 436/H.R. 488/H.R. 734: Medical Device Access and Innovation Protection Act (all provisions); HEU/LEU related issues for Nuclear Medicine. S.99: American Medical Isotopes Production Act (all provisions).

Issues involving controlled substance and pain and addiction drungs generally. Issues related to acetaminophen.

General issues related to FDA device approval process; Issues related to Patient Protection and Affordable Care Act Implementation (Accountable Care Organization Medical Device Tax); Medical Device Tax Repeal (S.17, S.262, H.R. 436, H.R. 488, H.R. 734); HEU/LEU related issues for Nuclear Medicine: S.99 - American Medical Isotopes Production Act- issues regarding all provisions.

International tax on foreign direct investment generally.

International tax on foreign direct investment generally.

Issues involving controlled substance and pain and addiction drungs generally. Issues related to acetaminophen.

S.23/H.R.1249 - America Invents Acts-regarding all provisions

General issues related to FDA device approval process; Issues related to Patient Protection and Affordable Care Act Implementation (Accountable Care Organization Medical Device Tax); Medical Device Tax Repeal (S.17, S.262, H.R. 436, H.R. 488, H.R. 734); HEU/LEU related issues for Nuclear Medicine: S.99 - American Medical Isotopes Production Act- issues regarding all provisions.

International tax on foreign direct investment generally.

Issues involving controlled substance and pain and addiction drungs generally. Issues related to acetaminophen.

S.515/H.R. 1260 - Patent Reform Act of 2009 (all provisions).

Issues related to Acetaminophen manufacturing.

General issues related to healthcare, healthcare reimbursement, and healthcare reform; S.1213 - Patient Centered Outcomes Research Act (all provisions); S.1142 - Informed Health Care Decision Making Act (all provisions); Issues related to FDA 510(K) legislative changes; S.1679 - Affordable Health Choice Act - issues related to comparative effectiveness and physicians sunshine; H.R. 3590 - Patient Protection and Affordable Care Act of 2009 - issues related to comparative effectiveness and physicians sunshine and medical device tax; S. 1796 - "The Americas Healthy Future Act of 2009" - issues related to comparative effectiveness, physicians sunshine and medical device fee; H.R. 4872 - The Healthcare & Education Affordability Reconciliation Act of 2010 - issues related to comparative effectiveness, physicians sunshine and medical device fee; Issues relating to the medical device tax/fee in general; H. Res. 1438 - Promoting Increased Awarness and Diagnosis of Peripheral Arterial Disease (all provisions); General issues related to BPA.

S.506 - Stop Tax Haven Abuse Act - provisions relating to international tax on foreign direct investment; H.R. 1265 - Stop Tax Haven Abuse Act - provisions relating to international tax on foreign direct investment; H.R. 4849 - Small Business and Infrastructure Jobs Tax Act of 2010 - international tax on foreign direct investment generally; International tax on foreign direct investment generally; H.R. 4213 - American Jobs and Closing Tax Loopholes Act of 2010 - provisions relating to international tax on foreign direct investment; H.R. 291 - Small business Jobs Act of 2010 (all provisions); S. 393 - Job Creation Tax Cuts Act - issues relating to international tax return.

H.R. 4173 - Wall Street Return and Consumer Protection Act - issues relating to end users.

HEU/LEU related issues for nuclear medicine; H.R. 3276 - American Medical Isotopes Production Act of 2009 (all provisions).

H.R. 4173 - Wall Street Return and Consumer Protection Act - provisions relating to end users.

Administration FY 2010 Budget.

S. 506 - Stop Tax Haven Abuse Act (all provisions); H.R. 1265 - Stop Tax Haven Abuse Act (all provisions); H.R. 4849 - Small Business and Infrastructure Jobs Tax Act of 2010 (all provisions); International tax on foreign direct investment generally.

General issues related to healthcare, healthcare reimbursement, and healthcare reform; S. 1213 - Patient Centered Outcomes Research Act (all provisions); H.R. 2502 - Comparative Effective Research Act of 2009 (all provisions); S. 1142 - Informed Health Care Decision Making Act (all provisions). S. 1679 - Affordable Health Choice Act (all provisions); H.R. 3590 - Patient Protection and Affordable Care Act of 2009 (all provisions); H.R. 3962 - Affordable Healthcare for American Act (all provisions); S. 1796 - "The Americas Healthy Future Act of 2009" (all provisions); Issues relating to the medical device tax/fee; Senate Finance Committee Healthcare Reform Bill; H.R. 4872 - The Healthcare & Education Affordability Reconciliation Act of 2010 (all provisions).

S. 515/H.R 1260 Patent Reform Act of 2009- issues regarding all provisions.

Administration FY 2010 Budget - issues related to international tax.

General Issues related to healthcare, healthcare reimbursement, healthcare reform, and the FDA device approval process; S.1213 Patient Centered Outcomes Rresearch Act- issues regarding all provisions; S. 1142 - Informed Health Care Decision Making Act- issues regarding all provision; Issues related to FDA 510(K) legislative changes; S.1679 - Affordable Health Choice Act- issues related comparative effectiveness & physicians sunshine; H.R. 3590 - Patient Protection and Affordable Care Act of 2009 - issues related comparative effectiveness & physicians sunshine and medical device tax; S. 1796 - "The Americas Healthy Future Act of 2009"- issues related to comparative effectiveness, physicians sunshine and medical device fee; H.R. 4872 - The Healthcare & Education Affordability Reconciliation Act of 2010- issues related to comparative effectiveness, physicians sunshine and medical device fee; Issues relating to the medical device tax/fee in general; House Resolutions 1438, Promoting Increased Awareness and Diagnosis of Peripheral Arterial Disease - Generally; General issues related to BPA.

General Issues related to healthcare, healthcare reimbursement, healthcare reform, and the FDA device approval process; S.1213 Patient Centered Outcomes research Act- issues regarding all provisions; S. 1142 - Informed health care Decision Making Act- issues regarding all provision; Issues related to FDA 510(K) legislative changes; S.1679 - Affordable Health Choice Act- issues related comparative effectiveness & physicians sunshine; H.R. 3590 - Patient Protection and Affordable Care Act of 2009 - issues related comparative effectiveness & physicians sunshine and medical device tax; S. 1796 - "The Americas Healthy Future Act of 2009"- issues related to comparative effectiveness, physicians sunshine and medical device fee; H.R. 4872 - The Healthcare & Education Affordability Reconciliation Act of 2010- issues related to comparative effectiveness, physicians sunshine and medical device fee; Issues relating to the medical device tax/fee in general; House Resolutions 1438, Promoting Increased Awareness and Diagnosis of Peripheral Arterial Disease - Generally

Issues related to Acetaminophen manufacturing.

HEU/LEU related issues for nuclear medicine; H.R. 3276 - American Medical Isotopes Production Act of 2009-issues regarding all provisions.

H.R. 4173 - Wall Street Return and Consumer Protection Act-issues relating to end users.

HEU/LEU related issues for nuclear medicine; H.R. 3276 - American Medical Isotopes Production act of 2009.

Financial Regulatory - issues relating to derivatives; H.R. 4173 - Wall Street Return and Consumer Protection Act; "Restoring American Financial Stability Act"

Issues related to comparative effectiveness; S.301 - Physician Payments Sunshine Act of 2009.

H.R. 3288 Fiscal 2010 Omnibus Appropriations; S.Con Res 13; H. Con Res 85; H.R. 1, American Recovery and Reinvestment Act of 2009; H.R. 2346/S. 1054 - Supplemental Appropriations Act (issues relating to pandemic flu); Fiscal 2010 Financial Services Approps.

HEU/LEU related issues for nuclear medicine; H.R. 3276 American Medical Isotopes Production Act of 2009.

Issues related to bariatric surgery; comparative effectiveness; S.301 - Physician Payments Sunshine Act of 2009.

S. 515/H.R.1260 - Patent Reform Act of 2009

General issues related to healthcare, healthcare reimbursement, and healthcare reform; S. 1213 - Patient Centered Outcomes Research Act; H.R. 2502-Comparative Effectiveness Research Act of 2009; S. 1142 Informed Health Care Decision Making Act. Tri-Committee healthcare reform Proposal; (H.R. 3200, America's Affordable Health Choice Act of 2009) S. 440/H.R. 1346 - Medical Devices Safety Act of 2009; S. 1679 Affordable Health Choice Act; H.R. 3590 Patient Protection and Affordable Care Act of 2009; H.R. 3962 Affordable Healthcare for American Act; S. 1796 "The Americas Healthy Future Act of 2009"; Issues relating to the medical device tax/fee; Senate Finance Committee Healthcare Reform Bill.

H.R.1105- Fiscal 2009 Omnibus appropriations; S. Con Res 13; H.Con Res 85; H.R. 1, American Recovery and Reinvestment Act of 2009; H.R. 2346/ S.1054- Supplemental Appropriations Act (issues relating to pandemic flu); Fiscal 2010 Financial Serves Approps.

Issues related to bariatric surgery; comparative effectiveness; S. 301- Physicians Payments Sunshine Act.

General issues related to healthcare, healthcare reimbursement, and healthcare reform; S. 1213 - Patient Centered Outcomes Research Act; H.R. 2502- Comparative Effectiveness Research Act of 2009; S. 1142 -Informed Health Care Decision Making Act. Senate Finance Committee Healthcare Reform Proposal-medical device tax; Tri-Committee Healthcare Reform Proposal; (H.R. 3200, America's Affordable Health Choice Act of 2009) S. 440/H.R.1346- Medical Device Safety Act of 2009; H.R. 2976/S. 1312- Medicare Safe Needles Disposal Coverage Act of 2009; S.1679 Affordable Health Choice Act.

H.R.1105- Fiscal 2009 Omnibus appropriations; S. Con Res 13; H.Con Res 85; H.R. 1, American Recovery and Reinvestment Act of 2009; H.R. 2346/ S.1054- Supplemental Appropriations Act (issues relating to pandemic flu); Fiscal 2010 Financial Services Approps.

S.560/H.R. 1409 - Employee Free Choice Act.

General issues related to healthcare, healthcare reimbursement, and healthcare reform; S. 1213 - Patient Centered Outcomes Research Act; H.R. 2502- Comparative Effectiveness Research Act of 2009; S. 1142 -Informed Health Care Decision Making Act. Kennedy HELP Committee Healthcare Reform Proposal; Senate Finance Committee Healthcare Reform Proposal; Tri-Committee Healthcare Reform Proposal; S. 440/H.R.1346- Medical Device Safety Act of 2009; H.R. 2976/S. 1312- Medicare Safe Needles Disposal Coverage Act of 2009.

Issues relating to healthcare generally, procurement, medicare/medicaid and foreign direct investment generally.

Issues relating to healthcare generally, procurement, medicare/medicaid and foreign direct investment generally.

Issues relating to healthcare generally, procurement, medicare/medicaid and foreign direct investment generally.

S.506, Stop Tax Haven Abuse Act; H.R 1265, Stop Tax Haven Abuse Act.

S. 515, H.R. 1260 - Patent Reform Act of 2009.

Issues related to competitive bidding and bariatric surgery; S. 301, Physicians Payments Sunshine Act.

FY2009 House Financial Services Appropriations; S 3260 FY09 Senate Financial Services Appropriations; FY2009 House Defense Appropriations; FY2009 Senate Defense Appropriations.

HR 1908, S 1145, Patent Reform Act of 2007

HR 2193 Animal Protection Accountability Improvement Act; HR 6381 Medical Device Safety Act; HR 6151 Responsibility in Drug and Device Advertising Act of 2008; General issues related to healthcare and healthcare reimbursement.

FY2009 House Financial Services Appropriations; S 3260 FY09 Senate Financial Services Appropriations; FY2009 House Defense Appropriations; FY2009 Senate Defense Appropriations.

HR 1908, S 1145, Patent Reform Act of 2007.

HR 1424 Paul Wellstone Mental Health and Addiction Equity Act, sec. 105, provisions related to Medicaid Drug Rebate; HR 5605 Physician Payments Sunshine Act of 2008; S 2029 Physician Payments Sunshine Act of 2007; HR 6331 Medicare Improvements for Patients and Provides Act; S 3101 Medicare Improvements for Patients and Providers Act of 2008/ S 3118 Preserving Access to Medicare Act 2008; HR 5765 Medicare Remote Monitoring Access Act of 2008; S 3144/HR 6252, Medicare DMEPOS Competitive Acquisition Reform Act 2008; Issues related to oxygen provisions, competitive bidding and bariatric surgery.

HR 1424, Paul Wellstone Mental Health and Addiction Equity Act - provisions related to Medicaid Drug Rebates HR 5605, Physician Payments Sunshine Act of 2008 S 2029, Physician Payments Sunshine Act of 2007 HR 6331, Medicare Improvements for Patients and Provides Act S 3101, Medicare Improvements for Patients and Providers Act of 2008/ S 3118, Preserving Access to Medicare Act 2008 HR 5765, Medicare Remote Monitoring Access Act of 2008 S 3144/HR 6252, Medicare DMEPOS Competitive Acquisition Reform Act 2008 S 2221, Transparency in Medicare Device Pricing Act Issues related to updated physician payments, oxygen provisions, competitive bidding and bariatric surgery.

HR 1908, S 1145, Patent Reform Act of 2007

General issues related to the healthcare industry; General issues regarding reimbursement and procurement for medical technology.

HR. 2419- Farm Bill Extension Act of 2007 - provisions related to durable medical equipment reimbursement and sales and marketing practices.

HR. 1424 Paul Wellstone Mental Health and Addiction Equity Act, Sec.105, provisions related to Medicaid Drug Rebate; HR. 3162 Children's Health and Medicare Protection Act of 2007; HR. 5605 Physician Payments Sunshine Act of 2008 S. 2029 Physician Payments Sunshine Act of 2007 S. 221 Transparency in Medicare Device Pricing Act. Issues related to updated physician payments oxygen provisions.

HR. 2419 - Farm Bill Extension Act of 2007 - provisions related to durable medical equipment reimbursement and sales and marketing practices.

HR. 1424 Paul Wellstone Mental Health and Addiction Equity Act, Sec.105, provisions related to Medicaid Drug Rebate; HR. 3162 Children's Health and Medicare Protection Act of 2007; HR. 5605 Physicians Payment Sunshine Act of 2008; S.2029 Physician Payments Sunshine Act of 2007. S.221 Transparency in Medicare Device Pricing Act Issues related to updated physician payments, oxygen provisions

General issues related to the healthcare industry; General issues regarding reimbursement and procurement for medical technology.

Uranium Enrichment Manufacturing; Uranium import/export.

HR.1845, S.1428 Medicare Durable Medical Equipment Access Act of 2007; S.2221 Transparency in the Medical Device Price Act of 2007; S.2029 Physician Payments Sunshine Act of 2007; S.2499 Medicare, Medicaid and SCHIP Extension Act of 2007;

S.1951, Fair Medicaid Drug Payment Act of 2007; HR.3140 Saving Our Community Pharmacies Act of 2007 AMP - Average Manufacturing Price; Pain Drugs and ANDA Applications; HR.3610 Food and Drug Import of Safety Act 2007;